The National Times - 'Mona's Eyes': how an obscure French art historian swept the globe

'Mona's Eyes': how an obscure French art historian swept the globe


'Mona's Eyes': how an obscure French art historian swept the globe
'Mona's Eyes': how an obscure French art historian swept the globe / Photo: © AFP

French art historian Thomas Schlesser is still adapting to life as a best-selling global author having written one of the break-out hits of the last year in "Mona's Eyes".

Change text size:

For a man more used to university lecture halls or the dry world of academic publishing, becoming a literary phenomenon, particularly in the United States, was unexpected.

"I was very surprised that the book achieved such success in France and abroad," Schlesser told AFP in an interview in Paris to promote his next work.

"The United States is an incredibly tough market since Americans read English-language authors," he added. "It goes without saying that I'm very happy, and very proud, but at the same time astonished."

The English translation of "Mona's Eyes" peaked at number four in The New York Times best-selling hard-back fiction chart shortly before Christmas and has sold an estimated 250,000 copies there.

Book-selling behemoth Barnes and Noble named it its book of the year.

Worldwide, it has been translated into 37 languages and has sold a million copies, around half of them in home market France where Schlesser has become a literary celebrity.

- Success formula -

It tells the story of a grandfather who educates his granddaughter Mona about the beauty of art after she is told by doctors she risks going blind.

The pair visit the most famous museums in Paris -- the Louvre, the Musee d'Orsay and the Pompidou Centre -- where Mona learns about everything from Renaissance work to abstractism.

Paris and its cultural heritage are a winning literary combination -- from The Hunchback of Notre Dame by Victor Hugo to The Da Vinci Code by Dan Brown -- but Schlesser thinks he hit a chord for other reasons.

"There’s a passion for the arts, but what I feel above all is universal sensitivity to the bonds around transmission between generations, between a grandfather and a granddaughter.

"And there's another very important thing, particularly among Americans I sensed, it's that 'Mona's Eyes' is a book that addresses the subject of disability," he added.

In an article about the "surprise hit novels" of 2025, The New York Times noted that at a time when thrillers and "sexy fantasy books about dragons" were the hottest reads, "'Mona’s Eyes' is something different."

Not everyone appreciated it, however.

A reviewer in Britain's Guardian newspaper sniffed that "an undeniable strain of sentimentalism runs throughout" the book and its prose.

- Poetry -

Schlesser, the tousle-haired son of a writer, is about to publish a follow-up of sorts called the "The Gardener’s Cat", which focuses on the healing power of poetry.

"I’ve been reading (poetry) since I was 12, and I make a point of reading at least one poem a day. It’s excellent for your well-being," he told AFP.

"The Gardener’s Cat" features Louis, a hypersensitive gardener devastated by the impending loss of his kitten, which has a tumour.

His new neighbour, Thalie, a retired literature teacher, lifts his spirits by introducing him -- over glasses of pastis liquor -- to some 80 poets, from Verlaine to Aimé Césaire, including Baudelaire and the Italian Gaspara Stampa.

"I can personally attest that poetry can truly save your life when you’re struggling. And even when you’re doing well, it can make life more intense," Schlesser explained.

He believes there is a "resurgence of poetry among younger generations".

Having helped popularise art and museum-going, he is hoping to have the same effect on the written word.

L.Graham--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: